A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.
In 2024, 6,889 cancer patients visited the institute, up from around 3,500 in 2020, with majority suffering from ...
Unhealthy dietary habits, including processed foods, high salt intake, and sugary drinks, are fueling the rise of stomach and ...
Researchers sought to determine trends and future patterns for liver, pancreatic, colorectal, stomach, and esophageal cancers in the US.
Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...
Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified ...
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...
Marwan G. Fakih, MD, provides an overview of the study design, rationale, and findings from a phase 2 trial of balstilimab with botensilimab for the treatment of patients with microsatellite stable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback